Advance Public Health through Vaccination

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 1944

Special Issue Editors


E-Mail
Guest Editor
Ministry of Health, 00144 Rome, Italy
Interests: vaccination policy: occupational health; mental health
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
School of Medicine, Saint Camillus International University of Health Sciences, UniCamillus, 00131 Rome, Italy
Interests: vaccine hesitancy; psychological support

E-Mail
Guest Editor
Department of Public Health Sciences and Paediatrics, University of Turin, 10126 Turin, Italy
Interests: vaccine hesitancy; public mental health
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy
Interests: prevention of infectious diseases; primary health care

Special Issue Information

Dear Colleagues,

Global health is continuously changing; thus, we are expecting to face various challenges in the form of epidemics and pandemics. Vaccines play an important role in mitigating these challenges. The worldwide effort to vaccinate people has demonstrated how immunization can prevent serious consequences, save lives, and protect communities. This Special Issue aims to investigate the evolving landscape of vaccination and explore solutions to achieve better vaccine uptake. We welcome original research, perspectives, and reviews that examine the latest advances in public health vaccination strategies, the role of vaccines in global health security, and ways to increase vaccination rates in vulnerable populations.

Dr. Maria Rosaria Gualano
Dr. Giuseppina Lo Moro
Dr. Gianluca Voglino
Dr. Erica De Vita
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epidemiology
  • vaccination strategies
  • vaccine hesitancy
  • health equity
  • vulnerable population

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 283 KiB  
Article
Integrated Surveillance of Disparities in Vaccination Coverage and Morbidity during the COVID-19 Pandemic: A Cohort Study in Southeast Sweden
by Armin Spreco, Örjan Dahlström, Dennis Nordvall, Cecilia Fagerström, Eva Blomqvist, Fredrik Gustafsson, Christer Andersson, Rune Sjödahl, Olle Eriksson, Jorma Hinkula, Thomas Schön and Toomas Timpka
Vaccines 2024, 12(7), 763; https://doi.org/10.3390/vaccines12070763 - 12 Jul 2024
Viewed by 298
Abstract
We aimed to use the digital platform maintained by the local health service providers in Southeast Sweden for integrated monitoring of disparities in vaccination and morbidity during the COVID-19 pandemic. The monitoring was performed in the adult population of two counties (n [...] Read more.
We aimed to use the digital platform maintained by the local health service providers in Southeast Sweden for integrated monitoring of disparities in vaccination and morbidity during the COVID-19 pandemic. The monitoring was performed in the adult population of two counties (n = 657,926) between 1 February 2020 and 15 February 2022. The disparities monitored were relocated (internationally displaced), substance users, and suffering from a psychotic disorder. The outcomes monitored were COVID-19 vaccination, SARS-CoV-2 test results, and hospitalization with COVID-19. Relocated residents displayed an increased likelihood of remaining unvaccinated and a decreased likelihood of testing as well as increased risks of primary SARS-CoV-2 infection and hospitalization compared with the general population. Suffering from a major psychiatric disease was associated with an increased risk of remaining unvaccinated and an increased risk of hospitalization but a decreased risk of SARS-CoV-2 infection. From the digital monitoring, we concluded that the relocated minority received insufficient protection during the pandemic, suggesting the necessity for comprehensive promotion of overall social integration. Persons with major psychiatric diseases underused vaccination, while they benefitted from proactively provided testing, implying a need for active encouragement of vaccination. Further research is warranted on legal and ethical frameworks for digital monitoring in vaccination programs. Full article
(This article belongs to the Special Issue Advance Public Health through Vaccination)
17 pages, 272 KiB  
Article
Assessment of Italian Population Awareness on One-Health, Zoonoses and the Mpox Vaccine: A Nationwide Cross-Sectional Study
by Fabrizio Bert, Giuseppina Lo Moro, Francesco Calabrese, Valentino Barattero, Alberto Peano, Giacomo Scaioli and Roberta Siliquini
Vaccines 2024, 12(3), 258; https://doi.org/10.3390/vaccines12030258 - 1 Mar 2024
Viewed by 1026
Abstract
In recent decades, the rise of zoonotic diseases has emerged as a significant human health concern, highlighting the interconnectedness of human and animal health within the framework of the “One Health” (OH) concept. This study, conducted in Italy in 2023, sought to gauge [...] Read more.
In recent decades, the rise of zoonotic diseases has emerged as a significant human health concern, highlighting the interconnectedness of human and animal health within the framework of the “One Health” (OH) concept. This study, conducted in Italy in 2023, sought to gauge the general population’s awareness of OH and zoonotic diseases while identifying influencing factors. Additionally, it aimed to assess awareness of an Mpox virus vaccine, particularly pertinent due to the 2022 outbreak across Europe. The online cross-sectional study encompassed 1058 participants, revealing that 54.26% were unfamiliar with OH and zoonoses. Median knowledge scores were 12 points (IQR = 9–15) for zoonoses and 8 points (IQR = 6–11) for OH. Notably, factors such as age, economic situation, healthcare employment, educational level, and health literacy significantly influenced knowledge scores. Merely 26.8% of participants were aware of the existence of an Mpox vaccine, with healthcare workers, individuals engaged in animal-related work, and non-heterosexual men demonstrating higher awareness. The findings underscored a limited public understanding of zoonotic diseases and One Health, with variations observed across specific demographic groups. Given the potential impact on public health, urgent educational initiatives are warranted. Moreover, the study highlighted a low awareness of the Mpox vaccine, emphasizing the necessity for targeted awareness campaigns directed at both professionals and the general public. Full article
(This article belongs to the Special Issue Advance Public Health through Vaccination)
Back to TopTop